← FDA DRUG APPROVALS

FDA ANDA · ANDA088463

TRIPLE SULFA

Sponsor: FOUGERA

APPLICATION
ANDA088463
TYPE
ANDA
ROUTE
VAGINAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRIPLE SULFADiscontinued
TRIPLE SULFA (SULFABENZAMIDE 184MG, SULFACETAMIDE 143.75MG, SULFATHIAZOLE) 172.5MG · TABLET · VAGINAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →